Oslo, 5 December 2024: Reference is made to the stock announcement published by
Observe Medical ASA (the "Observe Medical") on 5 December 2024 regarding the
final result of the subsequent offering and the partial conversion to shares of
certain loans from Navamedic ASA ("Navamedic") to Observe Medical.

Navamedic currently holds 4,222,727 shares in Observe Medical, equal to approx.
1.72% of the current shares and votes in Observe Medical. Following the issuance
and registration of the shares in both the subsequent offering and the shares to
be issued to Navamedic in connection with the conversion, the Observe Medical's
number of outstanding shares will be 288,876,175. The conversion will result in
Navamedic increasing its shareholding from 4,222,727 shares to 45,109,765
shares, resulting in Navamedic holding approx. 15.62% of the new number of
shares and votes in Observe Medical.

This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and sections 4-2 and 5-12 of the Norwegian
Securities Trading Act.